Hiroshi Oguchi

Nagoya University

Papers

1

Total Citations

12

H-Index

1

About

Hiroshi Oguchi is a leading figure in the field of radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) and advanced radiosurgery technologies. His major contribution lies in rigorously evaluating the clinical transition from traditional circular collimators to modern multileaf collimators (MLCs) in robotic radiosurgery systems, particularly for treating localized prostate cancer. His most cited work, a 2017 study with 12 citations, provides critical evidence demonstrating the superior clinical usefulness of MLCs in prostate SBRT, showing how this technological shift enhances treatment precision and efficacy. This research has directly informed clinical protocols, helping radiation oncologists adopt more conformal and safer dose delivery methods. Oguchi’s work is notable for bridging the gap between engineering innovation and practical patient care, ensuring that cutting-edge hardware translates into tangible clinical benefits. His studies are essential reading for medical physicists and radiation oncologists seeking to optimize SBRT workflows, and his impact is reflected in the continued adoption of MLC-based systems in robotic radiosurgery worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Clinical usefulness of <scp>MLC</scp>s in robotic radiosurgery systems for prostate <scp>SBRT</scp>
12 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Nagoya University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago